» Articles » PMID: 28445073

Plasminogen Activator Inhibitor-1 Is Critical in Alcohol-Enhanced Acute Lung Injury in Mice

Overview
Date 2017 Apr 27
PMID 28445073
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Chronic alcohol exposure is a clinically important risk factor for the development of acute respiratory distress syndrome, the most severe form of acute lung injury (ALI). However, the mechanisms by which alcohol sensitizes the lung to development of this disease are poorly understood. We determined the role of the antifibrinolytic protein plasminogen activator inhibitor-1 (PAI-1) in alcohol enhancement of experimental endotoxin-induced ALI. Wild-type, PAI-1, and integrin β mice were fed ethanol-containing Lieber-DeCarli liquid or a control diet for 6 weeks, followed by systemic LPS challenge. LPS administration triggered coagulation cascade activation as evidenced by increased plasma thrombin-antithrombin levels and pulmonary fibrin deposition. Ethanol-exposed animals showed enhanced PAI-1 expression and pulmonary fibrin deposition with coincident exaggeration of pulmonary inflammatory edematous injury. PAI-1 deficiency markedly reduced pulmonary fibrin deposition and greatly reduced inflammation and injury without impacting upstream coagulation. Interestingly, pulmonary platelet accumulation was effectively abolished by PAI-1 deficiency in ethanol/LPS-challenged mice. Moreover, mice lacking integrin αβ, the primary platelet receptor for fibrinogen, displayed a dramatic reduction in early inflammatory changes after ethanol/LPS challenge. These results indicate that the mechanism whereby alcohol exaggerates LPS-induced lung injury requires PAI-1-mediated pulmonary fibrin accumulation, and suggest a novel mechanism whereby alcohol contributes to inflammatory ALI by enhancing fibrinogen-platelet engagement.

Citing Articles

Identification of Potential Therapeutic Targets Against Anthrax-Toxin-Induced Liver and Heart Damage.

Wu L, Chen Y, Yan Y, Wang H, Guy C, Carney J Toxins (Basel). 2025; 17(2).

PMID: 39998071 PMC: 11861023. DOI: 10.3390/toxins17020054.


Mechanisms of COVID-19 Associated Pulmonary Thrombosis: A Narrative Review.

Niculae C, Hristea A, Moroti R Biomedicines. 2023; 11(3).

PMID: 36979908 PMC: 10045826. DOI: 10.3390/biomedicines11030929.


Antioxidant mitoquinone ameliorates EtOH-LPS induced lung injury by inhibiting mitophagy and NLRP3 inflammasome activation.

Sang W, Chen S, Lin L, Wang N, Kong X, Ye J Front Immunol. 2022; 13:973108.

PMID: 36059543 PMC: 9436256. DOI: 10.3389/fimmu.2022.973108.


Binding domain peptide ameliorates alveolar hypercoagulation and fibrinolytic inhibition in mice with lipopolysaccharide-induced acute respiratory distress syndrome Via NF-κB signaling pathway.

Wang Y, Wu Y, Liu B, Yang H, Qian H, Cheng Y Am J Transl Res. 2022; 14(6):3854-3863.

PMID: 35836863 PMC: 9274609.


Fibrinogen mediates cadmium-induced macrophage activation and serves as a predictor of cadmium exposure in chronic obstructive pulmonary disease.

Li F, Surolia R, Singh P, Dsouza K, Stephens C, Wang Z Am J Physiol Lung Cell Mol Physiol. 2022; 322(4):L593-L606.

PMID: 35200041 PMC: 8993524. DOI: 10.1152/ajplung.00475.2021.


References
1.
van Holten T, Bleijerveld O, Wijten P, de Groot P, Heck A, Barendrecht A . Quantitative proteomics analysis reveals similar release profiles following specific PAR-1 or PAR-4 stimulation of platelets. Cardiovasc Res. 2014; 103(1):140-6. DOI: 10.1093/cvr/cvu113. View

2.
OSullivan B, Michelson A . The inflammatory role of platelets in cystic fibrosis. Am J Respir Crit Care Med. 2005; 173(5):483-90. DOI: 10.1164/rccm.200508-1243PP. View

3.
Moss M, Burnham E . Chronic alcohol abuse, acute respiratory distress syndrome, and multiple organ dysfunction. Crit Care Med. 2003; 31(4 Suppl):S207-12. DOI: 10.1097/01.CCM.0000057845.77458.25. View

4.
Poole L, Arteel G . Transitional Remodeling of the Hepatic Extracellular Matrix in Alcohol-Induced Liver Injury. Biomed Res Int. 2016; 2016:3162670. PMC: 5098054. DOI: 10.1155/2016/3162670. View

5.
Roman J . Extracellular matrix and lung inflammation. Immunol Res. 1996; 15(2):163-78. DOI: 10.1007/BF02918505. View